Evaluate Medtech

A transparent and trusted source of market intelligence and consensus forecasting for

the medical device and diagnostic landscape .

For medical device companies, their advisors, and the investment community, there is great value in having an accurate, comprehensive view of the global medical device and diagnostic market. Use Evaluate Medtech to easily track, benchmark and forecast the market, to drive and validate commercial and investment decisions.

WHO WE HELP

With Evaluate Medtech, you can quickly understand how the market views your company and product portfolio, or those of your competitors, clients and potential new business partners. With a comprehensive picture of multiple market characteristics, you know which technologies and devices the market is focusing on - and where your opportunities, risks and priorities lie.

Investors, Consultants & Service Providers

Build a high-level understanding of the medical device and diagnostic market, grow your client portfolio, and validate investment decisions with globally trusted commercial intelligence.

Medical Device & Diagnostic Companies

Use our platform to evaluate and forecast the market, particularly your targeted segment. To inform strategic investment and product launch decisions.

YOU CAN:

• View company and device portfolios. Understand the competitive landscape, conduct M&A and licensing analysis to assess targets and build a client portfolio

• Characterise the market using in depth consensus sales & financial models.

• Use deal screening to identify potential new customers and understand their activity, comparable historical deals, deal terms and values

• Monitor, track and analyse the performance of clients to support strategic account planning

• Obtain the latest regulatory data and benchmark approval standards

• Track and analyse the performance of competitors and potential acquisition targets, partners and distributors

• Easily compare financial data for multiple companies, all in one place

YOU CAN:

• Monitor industry and financial trends, regulatory news and product pipelines to support strategic account planning

• Monitor changes in analyst forecasts for internal company segments and key competitor segments

• Use consensus forecasts (sales, profits, expenditure) for peer comparison

• Characterise the market to aid long-term strategic decision-making about market entries and exits

• Build a trusted internal fact-base to empower stakeholders to trust strategic decisions

• Use M&A and deals data to see companies and device segments receiving investment

Medtech

Best-In-Class Global Consensus Forecasts

Evaluate Medtech uses the same proprietary methodologies as Evaluate Pharma:

THE GOLD STANDARD FOR CONSENSUS FORECASTS.

Gain a richer understanding of market dynamics, investment opportunities and company portfolios with global consensus forecasts for product segment sales, company financials and market share, clinical trial activity, pipeline development, FDA regulatory applications and approvals, Japan PMDA approvals, EU CE Mark approvals, M&A and financial activities.

DOWNLOAD OUR BROCHURE

KEY FEATURES

COMPANY & MEDICAL DEVICE PORTFOLIOS

Classification system mapped to:
• Company device segments and FDA product codes
• Proprietary device portfolio, both marketed and R&D

INFORMATION

• Venture Financing, M&A, IPO, News & Clinical Trials
• Single source for CMS, CDC, CT, CUP, EUCOMED and OECD procedures data for trend analysis

DEALS & FINANCIALS

Company segment sales with:
• Market share and rankings
• Publicly disclosed details on R&D product information
• Medical device and diagnostics deals
• Venture financing activity by device classification

REGULATORY INSIGHT

Via Devices@FDA data including: 6 integrated databases, making it easy to search & extract the data:
• PMAs (with 1st PMA noted for your convenience)
• 510(k)s
• HDEs (Humanitarian Device Exemptions)
• BLAs (Biologic Device Approvals)
• PDPs (Product Development Protocols)
• Identifies FDA Highlighted New Medical Technologies